Early Access — free while we kick the tires
EdgarHawk

HOOVER R DAVID

Director

Director
1 filing analyzed · 1 company · Latest 2025-03-07

Companies

Company Buys Sells Direction
Elanco Animal Health Inc ELAN 1 0 Net buying

Activity

March 2025
medium
Buy
25,000 shares
$272,558
Significance 6/10

ELAN Director Hoover buys 25,000 shares at $10.90; 90-day prior buy returned +12.8%

Hoover R David, a Director of Elanco Animal Health Inc (ELAN), purchased 25,000 shares at $10.90 on 2025-03-05, expanding his holdings by 13.5% from 185,000 to 210,000 shares. This represents a $272,557.50 investment in an environment where ELAN trades at $11.14 (near the bottom of its 52-week range of $10.70–$18.45, down 39.6% from the 52-week high). His prior open-market purchase at ELAN on 2024-03-06 delivered a 90-day return of +12.8%, and his cross-ticker track record shows a 100.00% 90-day win rate with an average 90-day return of +12.8%. The stock has declined 7.4% over 30 days and 10.9% over 90 days from prior price levels, signaling a period of weakness. The company's fundamentals show a P/E of 3.10 and net income of $364,000,000.00 against revenue of $1,030,000,000.00, though annual revenue growth is minimal at +0.5%.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access